by mfenimore | Dec 13, 2023 | Uncategorized
Advanced and metastatic urothelial carcinoma (a/mUC) of the bladder comprises a small subset of all urothelial tumors but accounts for the majority of the rapid mortality associated with this disease. Over the last decade, accelerating basic science research has...
by mfenimore | Nov 28, 2023 | Uncategorized
Learn the best practice guidelines for diagnosing and treating IBS-C and how to effectively communicate with patients with IBS to improve clinical outcomes and increase patient and provider satisfaction.
by mfenimore | Nov 28, 2023 | Uncategorized
Multiple myeloma is the second-most-common hematologic malignancy in the United States with approximately 34,470 new cases diagnosed in the United States in 2022. Although multiple myeloma is an incurable disease, numerous active agents are available that, when used...
by mfenimore | Nov 28, 2023 | Uncategorized
This educational program focuses on the recognition, diagnosis, and management of patients with thyroid eye disease, the majority of whom remain undiagnosed and unaware of treatment options. The program combines flexible, self-directed learning, live group...
by mfenimore | Nov 28, 2023 | Uncategorized
As a result of the COVID-19 pandemic, we have learned valuable lessons pertinent to MS care. This includes knowledge about COVID-19 severity and infection risk (especially as it relates to DMT selection), a much greater understanding of how DMTs affect SARS-CoV-2...
